A translatable predictor of human radiation exposure

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Lucas, Joseph ^a   Dressman, Holly K ^a   Suchindran, Sunil ^a   Nakamura, Mai ^b   Chao, Nelson J ^b,c   Himburg, Heather ^b   Minor, Kerry ^b   Phillips, Gary ^b   Ross, Joel ^b   Abedi, Majid ^d   Terbrueggen, Robert ^d   Chute, John P ^b,e  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DxTerity Diagnostics   (United States)

^e Division of Oral Biology and Medicine School of Dentistry Broad Stem Cell Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; BLOOD SAMPLING; CHEMICAL LIGATION DEPENDENT PROBE AMPLIFICATION ASSAY; CHEMOTHERAPY; CLINICAL ARTICLE; DATA PROCESSING; DIAGNOSIS; DOSIMETRY; DRUG EXPOSURE; EX VIVO STUDY; FEMALE; GENDER; GENE EXPRESSION PROFILING; HUMAN; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PILOT STUDY; PREDICTION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; WHOLE BODY RADIATION; ADVERSE EFFECTS; ANALYSIS; ANIMAL; BLOOD; BLOOD CELL; ENVIRONMENTAL EXPOSURE; GENETICS; METABOLISM; MIDDLE AGED; PROCEDURES; RADIOMETRY; TRANSLATIONAL RESEARCH; YOUNG ADULT;

TRANSCRIPTOME;

ADULT; AGED; ANIMALS; BLOOD CELLS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; RADIATION DOSAGE; RADIATION INJURIES; RADIOMETRY; TRANSCRIPTOME; TRANSLATIONAL MEDICAL RESEARCH; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 84907588604     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107897     Document Type: Article

References (30)

1. Dainiak N, Gent R, Carr Z., Schneider A, Bader J, et al. (2011) First global consensus for evidence based management of the hematopoietic syndrome resulting from exposure to ionizing radiation. Disaster Med Public Health Prep 5: 202-212.
2. Mettler FA, Voelz G (2002) Major radiation exposure: what to expect and how to respond. N Engl J Med 346: 1554-1561.
3. Waselenko J, Macvittie T, Blakeley W., Pesik N, Wiley A, et al. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 140: 1037-1051, 2004.
4. Murrain-Hill P, Coleman CN, Hick J, Redlener I., Weinstock D, et al. (2011) Medical response to a nuclear detonation: creating a playbook for state and local planners and responders. Disaster Med Public Health Prep 5 Suppl 1: S89-97.
5. Coleman CN, Parker G (2009) Radiation terrorism: what society needs from the radiobiology-radiation protection and radiation oncology communities. J Radiol Prot 29 (2A): A159-169.
6. Meineke V, Dorr H (2012) The Fukushima radiation accident: consequences for radiation accident medical management. Health Phys 103: 217-220.
7. Blakely WF, Madrid JP, Sandgren D (2010) Biodosimetry medical recording-use of the Biodosimetry Assessment Tool. Health Phys 99 Suppl 5: S184-191.
8. Fleidner T, Chao N, Bader J., Boettger A, Case C, et al. (2009) Stem Cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop. Stem Cells 27: 1205-1211.
9. Weinstock D, Case C, Bader J., Chao N, Coleman CN, et al. (2008) Radiologic and nuclear events: contingency planning for hematologists/oncologists. Blood 111: 5440-5445.
10. Fleidner T, Powles R, Sirohi B., Niederwieser D (2008) Radiologic and nuclear events: the METREPOL severity of effect grading system. Blood 111; 5757-5758.
11. Coleman CN, Hrdina C, Bader J., Norwood A, Hayhurst R, et al. (2009) Medical response to radiologic/nuclear event: integrated plan from the Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services. Ann Emerg Med 53: 213-222.
12. Sullivan J, Prasanna P, Grace M., Wathen L, Wallace R, et al. (2013) Assessment of biodosimetry methods for a mass-casualty radiological incident: medical response and management considerations. Health Phys 105: 540-554.
13. Dressman H, Muramoto G, Chao N., Meadows S, Marshall D, et al. (2007) Gene expression signatures that predict radiation exposure in mice and humans. PLoS Med 4: e106.
14. Meadows S, Dressman H, Muramoto G., Himburg H, Salter A, et al. (2008) Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. PLoS ONE 3: e1912.
15. Meadows S, Dressman H, Daher P., Himburg H, Russell JL, et al. (2010) Diagnosis of partial body radiation exposure in mice using peripheral blood gene expression profiles. PLoS ONE 5: e11535.
16. Badie C, Kabacik S, Balagurunathan Y., Bernard N, Brengues M, et al. (2013) Laboratory intercomparison of gene expression assays. Radiat Res 180: 138-148.
17. Bild A, Yao G, Chang J., Wang Q, Potti A, et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
18. Amundson S, Bittner M, Meltzer P., Trent J, Fornace A (2001) Induction of gene expression as a monitor of exposure to ionizing radiation. Radiat Res 156: 657-661.
19. Matsumoto T, Wang P, Ma W., Sung H, Matoba S, et al. (2009) Polo-like kinases mediate cell survival in mitochondrial dysfunction. Proc Natl Acad Sci USA 106: 14542-14546.
20. Pawlik TM, Keyomarsi A (2004) Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59: 928-942.
21. Amundson S, Do K, Shahab S., Bittner M, Meltzer P, et al. (2000) Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat Res 154: 342-346.
22. Amundson S, Bittner M, Meltzer P., Trent J, Fornace A (2001) Biological indicators for the identification of ionizing radiation exposure in humans. Expert Rev Mol Diagn 1: 211-219.
23. Amundson S, Fornace A (2003) Monitoring human radiation exposure by gene expression profiling: possibilities and pitfalls. Health Phys 85: 36-42.
24. Paul S, Barker C, Turner H., McClane A, Wolden S, et al. (2011) Prediction of in vivo radiation dose status in radiotherapy patients using ex vivo and in vivo gene expression signatures. Radiat Res 175: 257-265.
25. Riecke A, Rufa G, Cordes M., Hartmann J, Meineke V, et al. (2012) Gene expression comparisons performed for biodosimetry purposes on in vitro peripheral blood cellular subsets and irradiated individuals. Radiat Res 178: 234-243.
26. Mestas J, Hughes C (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172: 2731-2738.
27. Wilkins RC, Ng C, Raaphorst G (1998) Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro. Radiat Oncol Investig 6: 209-215.
28. Albanese J, Martens K, Karkanitsa L., Dainiak N (2007) Multivariate analysis of low-dose radiation-associated changes in cytokine gene expression profiles using microarray technology. Exp Hematol 35: 47-54.
29. Straume T, Amundson S, Blakely W., Burns W, Chen A, et al. (2008) NASA radiation biomarker workshop, September 27-28, 2007. Rad Res 170: 393-405.
30. Schreyer S, Karkanitsa L, Albanese J., Ostapenko V, Shevchuk V, et al. (2002) Analysis of radiation-associated changes in gene expression using microarray technology. Brit J Radiol, Supple 26: 129-139.